SAGE RHINO CAPITAL LLC 13D/13G Filings for Vincerx Pharma, Inc. (VINC)

SAGE RHINO CAPITAL LLC 13D and 13G filings for Vincerx Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-08-04
2:23 pm
Unchanged
2021-03-0413GVincerx Pharma, Inc.
VINC
SAGE RHINO CAPITAL LLC0
0.000%
0
(Unchanged)
Filing